There is no known underlying genetic defect predisposing patients ? to develop primary intraocular lymphoma (PIOL). Discovery of genetic ? factors predisposing to the development of PIOL would be of benefit for ? early diagnosis, prognostic staging, and development of novel treatments ? for PIOL. Until recently, genetic approaches to investigate the etiology ? of cancer have relied upon methods utilizing linkage based on traditional ? Mendelian inheritance patterns. It is probable that many diseases are a ? consequence of multiple genetic factors, and are therefore less amenable ? to study using traditional methods of linkage analysis and positional ? cloning to isolate single genes. Single nucleotide polymorphisms (SNPs) ? are the most common sources of variation in the human genome. SNPs are ? single-base differences in the DNA sequence that can be observed among ? individuals in a population. A SNP is defined on the basis of a frequency ? of at least 1% prevalence in one or more populations. SNPs are present ? throughout the genome at an average frequency of 1/1000 base pairs. We ? propose to analyze the frequency of SNPs specifically within the coding ? frames of biologically plausible genes responsible for function of the ? innate immune system. The interleukins are a specific pathway of interest ? because previous research has demonstrated derangements in the ratios of ? interleukins 10 and 6 in the vitreous humor and spinal fluid of patients ? with PIOL, leading to the hypothesis that altered function or expression ? of these or other interleukins could permit the development of this rare ? malignancy. Samples continue to be collected, but as no results have yet ? been obtained. We hosted a workshop on this subject at the NIH this past ? fiscal year with the results recently published. Since recruitment for ? this study was very slow we have made the decision to suspend this study. ? However, we received a Bench to Bedside award to begin to investigate the use of a ? CD-22/pseudomonas construct in order to kill intraocular tumor. Initial ? studies have been promising with our plan to carry these further in animal ? studies and ultimately to the treatment of patients.? From 2005 to 2007, we have made substantial progress in establishing a ? murine model to mimic human PIOL as well as searching for novel and ? effective therapy for this disease. We have established a mouse model that ? resembles human PIOL at the level of histopathology and molecular ? pathogenesis. We demonstrated that the model shares several hall mark ? characteristics of human PIOL and is ideal for further studying the ? molecular mechanisms of human PIOL. Furthermore, in collaboration with ? NCI, we found that a recently developed immunotoxin (HA22) can eradicate ? the tumor with minimal toxicity and is potentially a novel therapeutic ? agent for treating human PIOL. Currently, we are investigating the toxicity of HA22 ? to ocular tissues using a rabbit model.
| Palmer, Douglas C; Chan, Chi-Chao; Gattinoni, Luca et al. (2008) Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A 105:8061-6 |
| Cortes, Lizette M; Mattapallil, Mary J; Silver, Phyllis B et al. (2008) Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci 49:1946-56 |
| Kurup, Shree K; Levy-Clarke, Grace; Calvo, Katherine R et al. (2007) Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids. Clin Experiment Ophthalmol 35:468-72 |
| O'Mahony, Deirdre; Morris, John C; Quinn, Cate et al. (2007) A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res 13:958-64 |
| Li, Zhuqing; Mahesh, Sankaranarayana P; Shen, De Fen et al. (2006) Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma. Cancer Res 66:10586-93 |
| Wallace, Dana J; Shen, DeFen; Reed, George F et al. (2006) Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 47:2750-6 |
| Wallace, Dana J; Altemare, Chandra R; Shen, De Fen et al. (2006) Primary testicular and intraocular lymphomas: two case reports and a review of the literature. Surv Ophthalmol 51:41-50 |
| Nussenblatt, Robert B; Chan, Chi-Chao; Wilson, Wyndham H et al. (2006) International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future. Ocul Immunol Inflamm 14:139-44 |
| Levy-Clarke, Grace A; Chan, Chi-Chao; Nussenblatt, Robert B (2005) Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 19:739-49, viii |
| Wolf, Lesley A; Reed, George F; Buggage, Ronald R et al. (2003) Vitreous cytokine levels. Ophthalmology 110:1671-2 |
Showing the most recent 10 out of 12 publications
